CORDIS
EU research results

CORDIS

English EN
Protecting patients with enhanced susceptibility to infections

Protecting patients with enhanced susceptibility to infections

Objective

The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL will recruit 16 international ESRs, who will be trained in research, transferable skills, and network and capacity building. They will be guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Rheumatology and Immunology, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG.

26 partner organisations, including 14 private sector partners, are committed to support ESR training via mentoring, courses and secondments. Research training builds on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrates fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry will increase the ESRs future problem-solving capabilities.

Further, ESRs will learn to value mobility through internships at international partner organizations. By providing an excellent scientific working environment PRONKJEWAIL will directly impact on hospital care and, ultimately, it will contribute to enhanced public health. By providing excellent training, PRONKJEWAIL will develop new talent within the next generation of medical researchers thereby strengthening the European Research Area.

Coordinator

ACADEMISCH ZIEKENHUIS GRONINGEN

Address

Hanzeplein 1
9713 Gz Groningen

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 674 240

Partners (26)

Sort alphabetically

Expand all

KAROLINSKA INSTITUTET

UNIVERSITETET I BERGEN

VISMEDERI SRL

THE UNIVERSITY OF LIVERPOOL

MSD BV

QUEEN MARGARET UNIVERSITY, EDINBURGH

Edinburgh Molecular Imaging Ltd

Universitätsklinikum Tübingen

Check-Points

National Enterovirus Reference Center

Labhelp International BV

COPAN

ThermoFisher Scientific

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

STICHTING WETSUS, EUROPEAN CENTRE OF EXCELLENCE FOR SUSTAINABLE WATER TECHNOLOGY

Institute of Photonic Technology Leibniz

KING'S COLLEGE LONDON

CHR. HANSEN A/S

NUTRICIA RESEARCH BV

THE UNIVERSITY OF ADELAIDE

UCB-Pharma

JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

University Chest Clinic Lasi

MAD multimedia

GILEAD SCIENCES INC

Integrated Disease Management Corporation bv

Project information

Grant agreement ID: 713660

Status

Ongoing project

  • Start date

    1 September 2016

  • End date

    31 August 2021

Funded under:

H2020-EU.1.3.4.

  • Overall budget:

    € 3 348 480

  • EU contribution

    € 1 674 240

Coordinated by:

ACADEMISCH ZIEKENHUIS GRONINGEN

Netherlands